Disclaimer
The content is intended for officially approved health care providers.
Please click "I'm a health care provider" to confirm that you are a health care provider.
If you are not a health care provider, please click "Go back home"
I'm a health care provider
Go back home
Nordic Migraine Symposium 2024
Click here to view summary of the ajovy SmPc available here (in Danish)
Session 0: Opening lecture
Anti-CGRP therapies: similar but not the same
Antoinette Maassen van den Brink
Professor of Neurovascular Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Session 1: New treatments – Evaluation and management
When to evaluate effectiveness?- Anti-CGRPs and gepants
Erling Tronvik
MD, PhD - Scientific Director of NorHEAD, Senior Consultant at St.Olav University Hospital and Professor at Department of Neuromedicine and Movement Science, NTNU - Trondheim, Norway
When to switch? Anti-CGRPs and gepants
Bianca Raffaelli
Neurology consultant, Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany
Session 2: Controversies in migraine treatment
Does vestibular migraine exist? Pro
Vlasta Vukovic Cvetkovic
M.D, PhD; neurologist, senior consultant, Danish Headache Center & Department of Neurology, Rigshospitalet-Glostrup, Denmark
Does vestibular migraine exist? Con
Jan Versijpt
MD PhD, Department of Neurology, University Hospital Brussels, Belgium
Do we need drug holidays? Pro
Lars Bendtsen
Associate professor, Clinical director of the Danish Headache Center, Department of Neurology, Rigshospitalet - Glostrup, University of Copenhagen, Denmark
Do we need drug holidays? Con
Tine Poole
Neurologist, MD, PhD, Sandvika Nevrosenter, Norway
Session 3: Rare types of migraine and their treatment
Trigeminal autonomic cephalalgias or migraine?
Anna Sundholm
MD PhD, Head of ME Neurology, Karolinska University Hospital, Sweden
TTH or CM or both? Multiple diagnosis
Aud Dueland
MD, PhD, Clinical Neurologist Sandvika Nevrosenter, Norway
Session 4: Is there evidence…
for treating in the prodromal phase?
Koen Paemeleire
Prof., MD, PhD, Department of Neurology, Ghent University Hospital Ghent, Belgium
for using triptan during the aura phase?
Ville Artto
MD, PhD, Senior Neurologist, Department of Neurology, Helsinki University Hospital, Finland
for neuroinflammation in migraine?
Rune Häckert
MD, PhD-fellow, Danish Headache Center & Dept. of Neurology University of Copenhagen, Rigshospitalet Glostrup, Denmark
Session 5: The future of migraine management
PACAP in migraine and cluster headache
Messoud Ashina
Professor of Neurology, Danish Headache Center & Dept. of Neurology University of Copenhagen, Rigshospitalet Glostrup, Denmark
Swedish digi-physical headache center
Mattias Linde
Head consultant Regional Migränmottagning Sahlgrenska, Professor Norwegian Centre for Headache Research (NorHEAD), Vice chairman Swedish Headache Society
Artificial intelligence in migraine management
Paolo Alonge
MD, neurology resident, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.) University of Palermo, Italy